Evidence map›Paper›PMID 33420318›Full record

ArticleCommunications biology2021

The spatial RNA integrity number assay for in situ evaluation of transcriptome quality.

Linda Kvastad, Konstantin Carlberg, Ludvig Larsson, Eva Gracia Villacampa, Alexander Stuckey, Linnea Stenbeck, Annelie Mollbrink, Margherita Zamboni, Jens Peter Magnusson, Elisa Basmaci and 7 more

Abstract readEvaluation Study
In one paragraph

Article in Communications biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Plants (Basel, Switzerland) · 2024
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Linda KvastadScience for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.ORCID 0000-0001-5869-3485
Konstantin CarlbergScience for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.
Ludvig LarssonScience for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.
Eva Gracia VillacampaScience for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.ORCID 0000-0003-0353-2101
Alexander StuckeyScience for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.
Linnea StenbeckScience for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.ORCID 0000-0002-0210-7886
Annelie MollbrinkScience for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden.
Margherita ZamboniDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0003-0664-4707
Jens Peter MagnussonDepartment of Cell and Molecular Biology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-3928-8959
Elisa BasmaciDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Alia ShamikhDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Gabriela ProchazkaDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.
Anna-Lena SchauppNuffield Department of Clinical Neurosciences, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital University of Oxford, Oxford Centre for Neuroinflammation, Oxford, UK.
Åke BorgDivision of Oncology and Pathology, Department of Clinical Sciences, Lund Lund University, Lund, Sweden.ORCID 0000-0002-5793-132X
Lars FuggerNuffield Department of Clinical Neurosciences, MRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, John Radcliffe Hospital University of Oxford, Oxford Centre for Neuroinflammation, Oxford, UK.
Monica NistérDepartment of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.ORCID 0000-0002-1261-3790
Joakim LundebergScience for Life Laboratory, KTH - Royal Institute of Technology (KTH), SE-171 65, Solna, Sweden. joakim.lundeberg@scilifelab.se.ORCID 0000-0003-4313-1601

Funding

Medical Research Council MC_UU_12010/3Wellcome TrustWellcome Trust 100308/Z/12/Z
6 · The paper itself

Abstract

The RNA integrity number (RIN) is a frequently used quality metric to assess the completeness of rRNA, as a proxy for the corresponding mRNA in a tissue. Current methods operate at bulk resolution and provide a single average estimate for the whole sample. Spatial transcriptomics technologies have emerged and shown their value by placing gene expression into a tissue context, resulting in transcriptional information from all tissue regions. Thus, the ability to estimate RNA quality in situ has become of utmost importance to overcome the limitation with a bulk rRNA measurement. Here we show a new tool, the spatial RNA integrity number (sRIN) assay, to assess the rRNA completeness in a tissue wide manner at cellular resolution. We demonstrate the use of sRIN to identify spatial variation in tissue quality prior to more comprehensive spatial transcriptomics workflows.

Indexed as

Spatial AnalysisTranscriptomeCell Line, TumorHumansRNA, MessengerRNA, Messenger

Identifiers

PMID33420318
PMCPMC7794352

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.